The Pfizer 'FACTORy' programme, developed in New Zealand by bcg2 Health in collaboration with Spitfire, then launched into Australia, has won a Pfizer Human Health global award for commercial excellence and innovation. Pfizer 'FACTORy' was selected for one of eight awards from 278 entries from Pfizer subsidiaries around the world.